Our Investments
In addition to our businesses we have a portfolio of smaller investments.
ADial Pharmaceuticals
ADial Pharmaceuticals develops prescription medications for addictions and related disorders.

About

ADial Pharmaceuticals focuses on gene-specific medication to treat addiction and related disorders. The medications target multiple neurotransmitters and brain pathways, which can help change how substance abuse is treated. ADial’s two most advanced compounds specifically target alcohol abuse and dependence.

History

ADial Pharmaceuticals is a start-up, with headquarters in Charlottesville, Virginia, USA.

Ownership

Lindéngruppen’s stake in ADial Pharmaceuticals is approximately 10%. 

For more information please visit www.adialpharma.com

Property and agriculture
Lindéngruppen owns a modest portfolio of industrial and commercial properties.

Lindéngruppen has invested in a limited number of industrial and commercial properties. It is also engaged in agriculture via Pilskytten Lantbruk.

Spintop Ventures
Spintop Ventures supports entrepreneurs by investing in early stage technology companies.

About

Spintop Ventures is often the first external investor and seeks to leverage technology that disrupts existing industry structures. The company partners' extensive experience and global network are used to develop the chosen companies. Spintop also provides co-investment opportunities and Lindéngruppen has participated in direct co-investments in their portfolio companies.

History

Spintop Ventures was founded by Mats Johansson, Finn Persson and Erik Wenngren, and have main offices in Malmö, Sweden, and London, UK.

Ownership

Spintop Ventures is owned by the founding partners and Lindéngruppen has invested approximately 10% of the total capital in their first fund, and approximately 30% in the second.

For more information please visit www.spintopventures.com